Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
Christoph C KaufmannAmro AhmedMona KassemMatthias K FreynhoferBernhard JägerGabriele AicherSusanne Equiluz-BruckAlexander O SpielFlorian Vafai-TabriziMichael GschwantlerPeter FaschingJohann WojtaEvangelos GiannitsisKurt HuberPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)
The combination of raised copeptin and hs-cTnI upon admission is an independent predictor of ICU admission or 28-day mortality in hospitalized patients with COVID-19.